Thu, Jan 29, 2015, 3:31 PM EST - U.S. Markets close in 29 mins.

Recent

% | $
Quotes you view appear here for quick access.

Theravance Inc. Message Board

  • larrystone13 larrystone13 Mar 4, 2013 3:39 PM Flag

    Motley Fool Just Out " Glaxo & THRX Hookup Is a No Brainer" LINK

    Why Theravance Shares Soared
    By Sean Williams | More Articles | Save For Later
    March 4, 2013 | Comments (0)
    Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
    What: Shares of biotechnology company Theravance (NASDAQ: THRX ) shot up as much as 18% after brokerage firm Piper Jaffray insinuated that a positive outcome from the FDA regarding Breo Ellipta, which has a PDUFA date of March 7, could create a takeover opportunity.
    So what: Breo Ellipta -- which combines a long-acting beta agonist with an inhaled corticosteroid for 24-hour, long-term COPD relief -- uses components from both Theravance and GlaxoSmithKline (NYSE: GSK ) . Glaxo actually owns a 25% stake in Theravance to begin with, and they currently have multiple COPD treatments in clinical trials and/or working their way through the FDA review process, so a buyout, assuming approval, could make logistical sense.
    Now what: Don't say I haven't already climbed this tree -- because I have. My exact words on Jan. 25 with regard to which biotech was the next buyout candidate were, "Personally, I'd call a hookup between Theravance and GlaxoSmithKline a no-brainer. Theravance and Glaxo have been like peanut butter and jelly when it comes to developing revolutionary new COPD treatments." I really don't see anything on the safety side of things that would preclude Breo Ellipta from an approval later this week, so I'd agree that Piper Jaffray is pro

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
THRX
11.00+0.06(+0.55%)3:31 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.